PE20060868A1 - Sales de aminio de 1,2,3- triazoles como profarmacos que incluyen agentes antivirales - Google Patents
Sales de aminio de 1,2,3- triazoles como profarmacos que incluyen agentes antiviralesInfo
- Publication number
- PE20060868A1 PE20060868A1 PE2006000002A PE2006000002A PE20060868A1 PE 20060868 A1 PE20060868 A1 PE 20060868A1 PE 2006000002 A PE2006000002 A PE 2006000002A PE 2006000002 A PE2006000002 A PE 2006000002A PE 20060868 A1 PE20060868 A1 PE 20060868A1
- Authority
- PE
- Peru
- Prior art keywords
- antiviral agents
- propharmacs
- triazoles
- hiv
- halogen
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title abstract 3
- 150000000177 1,2,3-triazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000030507 AIDS Diseases 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000956 methoxy group Chemical class [H]C([H])([H])O* 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 abstract 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 abstract 1
- 229960005475 antiinfective agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES H, HALOGENO, METOXI; W ES II; R4, R5, R6, R7, R8, R9, R10 Y R11 SON CADA UNO H, METILO, CON LA CONDICION DE QUE NO MAS DE 2 SON METILO; R12 ES C(O)-FENILO; Y ES HALOGENO, O(C)OCH3, OC(O)CF3, ENTRE OTROS. UN COMPUESTO PREFERIDO ES: TRIFLUOROACETATO DE 1-AMINO-3-{3-[2-(BENZOIL-PIPERAZINIL-1-IL)-2-OXO-ACETIL]-4-FLUORO-1H-PIRROLO[2,3-c]PIRIDIN-7-IL}-3H-[1,2,3]TRIAZOL-1-IO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE CONTIENE ADEMAS: A) UN AGENTE ANTIVIRAL CONTRA EL SIDA; B) UN AGENTE ANTIINFECCIOSO; C) UN INMUNOMODULADOR Y D) INHIBIDORES DE LA ENTRADA DE VIH. DICHOS COMPUESTOS SON PROFARMACOS PARA MEJORAR LA SOLUBILIDAD O LAS PROPIEDADES FARMACEUTICAS DE LOS COMPUESTOS QUE CONTIENEN 1,2,3-TRIAZOL, UTILES COMO AGENTES ANTIVIRALES Y ESPECIFICAMENTE PARA EL TRATAMIENTO DE VIH Y SIDA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64018504P | 2004-12-29 | 2004-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060868A1 true PE20060868A1 (es) | 2006-08-23 |
Family
ID=36553758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000002A PE20060868A1 (es) | 2004-12-29 | 2006-01-03 | Sales de aminio de 1,2,3- triazoles como profarmacos que incluyen agentes antivirales |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7183284B2 (es) |
| AR (1) | AR054103A1 (es) |
| PE (1) | PE20060868A1 (es) |
| TW (1) | TW200635925A (es) |
| WO (1) | WO2006071564A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
| US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| CN103328452A (zh) * | 2010-12-13 | 2013-09-25 | 威尔金制药有限公司 | 金属酶抑制剂化合物 |
| US20160052923A1 (en) * | 2013-03-27 | 2016-02-25 | Bristol-Myers Squibb Company | Piperazine and homopiperazine derivatives as hiv attachment inhibitors |
| PT2978763T (pt) * | 2013-03-27 | 2018-04-16 | Viiv Healthcare Uk No 5 Ltd | Derivados de 2-cetoamida como inibidores da ligação do vih |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219892A (en) | 1986-04-15 | 1991-02-26 | Merck & Co Inc | N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof |
| KR940000112B1 (ko) | 1990-07-05 | 1994-01-05 | 주식회사 대웅제약 | 신규의 3-치환 세펨화합물 및 그의 제조방법 |
| US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| US6573262B2 (en) | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| US20030207910A1 (en) | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| IL157029A0 (en) | 2001-02-02 | 2004-02-08 | Bristol Myers Squibb Co | Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| WO2003082881A2 (en) | 2002-03-28 | 2003-10-09 | Procyon Biopharma Inc. | Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors |
| US7037913B2 (en) | 2002-05-01 | 2006-05-02 | Bristol-Myers Squibb Company | Bicyclo 4.4.0 antiviral derivatives |
| US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
-
2005
- 2005-12-12 US US11/301,046 patent/US7183284B2/en not_active Expired - Fee Related
- 2005-12-15 WO PCT/US2005/045591 patent/WO2006071564A2/en not_active Ceased
- 2005-12-22 TW TW094145889A patent/TW200635925A/zh unknown
- 2005-12-28 AR ARP050105612A patent/AR054103A1/es unknown
-
2006
- 2006-01-03 PE PE2006000002A patent/PE20060868A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200635925A (en) | 2006-10-16 |
| AR054103A1 (es) | 2007-06-06 |
| WO2006071564A3 (en) | 2007-04-12 |
| US7183284B2 (en) | 2007-02-27 |
| US20060142298A1 (en) | 2006-06-29 |
| WO2006071564A2 (en) | 2006-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| CR8744A (es) | Compuestos terapeuticos | |
| PA8593101A1 (es) | Composiciones para el tratamiento de crecimiento celular anormal | |
| UY29633A1 (es) | Derivados de oxindol | |
| SE0202463D0 (sv) | Novel compounds | |
| UY28510A1 (es) | Compuestos quimicos | |
| MXPA05012247A (es) | Derivados de bencimidazol nuevos. | |
| ECSP045407A (es) | Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| HRP20060254A2 (en) | Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | |
| PE20060524A1 (es) | Compuestos heterociclico fusionados como intermediarios en la preparacion de pirrolotriazinas inhibidoras de cinasa | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| AR048039A1 (es) | Profarmacos de piperazina y agentes antivirales de piperidina sustituidos | |
| ECSP056127A (es) | Inhibidores de 3-quinasa de fosfatidil-inositol | |
| PE20010286A1 (es) | Derivados de indoloxoacetil piperazina como agentes antivirales | |
| AR053569A1 (es) | Derivados de pirazol | |
| ECSP088967A (es) | Agonistas del receptor muscarínico que son efectivos en el tratamiento del dolor, la enfermedad de alzheimer y la esquizofrenia | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| DK1643984T3 (da) | Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler | |
| SE0302546D0 (sv) | New compounds | |
| UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| AR056860A1 (es) | Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |